<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>S100 &#8211; Ipracell</title>
	<atom:link href="https://www.ipracell.be/product-category/s100/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.ipracell.be</link>
	<description>Production &#38; exploitation of mammalian cells</description>
	<lastBuildDate>Thu, 08 Jan 2026 11:57:29 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.7.4</generator>

<image>
	<url>https://www.ipracell.be/wp-content/uploads/2025/02/cropped-Favicon-32x32.png</url>
	<title>S100 &#8211; Ipracell</title>
	<link>https://www.ipracell.be</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>HeLa S100 Cytoplasmic Extracts</title>
		<link>https://www.ipracell.be/product/hela-s100-cytoplasmic-fraction/</link>
		
		<dc:creator><![CDATA[dsergeant]]></dc:creator>
		<pubDate>Wed, 12 Apr 2017 13:24:54 +0000</pubDate>
				<guid isPermaLink="false">http://new.ipracell.be/?post_type=product&#038;p=77</guid>

					<description><![CDATA[<p>Volume:from 420ul to 42ml. Hela cells pellets harvest in exponential phase and S100 Cytoplasmic Extracts are prepared from fresh cells only.</p>]]></description>
										<content:encoded><![CDATA[<p><strong>HeLa cell</strong><br>The HeLa cell line was established from an adenocarcinoma of the cervix in 1952. It is the first continuous human cell line.</p>
<p><strong>Quality Control</strong><br>Cultures are screened for the presence of bacteria, yeast, fungi and mycoplasma (DNA amplification). NBCS used in the culture medium is certified from New Zealand origin.</p>
<p><strong>HeLa S100 Cytoplasmic Extracts Production</strong><br>HeLa cells are grown in sonoperfused fedbatch (cytostat) mode at a constant concentration of 5&#215;10<sup>6</sup> cells/ml (cell viability: 93%-99%) under GLP conditions in our facility in Mons, Belgium. Cells are harvested in exponential phase.</p>
<p>Ipracell, provider of high quality HeLa Nuclear Extract (HNE) expands its activities by making available the cytoplasm prepared from exponentially growing HeLa cells (HeLa Cytoplasmic Extract: HCE).<br>HCE is a rich source of:</p>
<ul>
<li>complexes (40S, 60S ribosomal subunits and 80S ribosomes etc&#8230;)</li>
<li>Factors involved in translation (eIFs&#8217;, IRES- and PolyA binding proteins).</li>
<li>Factors which play a role on different parts of the mRNA molecule (5&#8242;- and 3&#8242; UTRs&#8217;).</li>
</ul>
<p>It can be used to study the regulation of muRNA processing, mRNA polymorphism etc&#8230;<br>Preliminary data suggest that HCE compares favorably with the rabbit reticulocyte lysate for cell-free protein expression.<br>HCE production automation makes it possible to offer this subcellular fraction of high and reproducible quality at very competitive prices.</p>
<p><strong>Research Use</strong><br>Our HeLa S100 Cytoplasmic Extracts are used by research or production entities worldwide for the study of biochemical processing, high throughput screening or purification of biological material from human origin.</p>
<p>Also suitable for use in:</p>
<ul>
<li><em>in vitro</em> splicing;</li>
<li>protein-DNA/RNA and protein-protein interactions;</li>
<li>source of individual splicing factors and other regulatory proteins.</li>
</ul><p><strong>Downloads &#8211; Documents</strong></p><div class="wp-block-file"><a href="https://www.ipracell.be/wp-content/uploads/2019/08/Material-Safety-Data-Sheet-HeLa-cytoplasmic-S100.pdf">Material-Safety-Data-Sheet-HeLa-cytoplasmic-S100</a><a href="https://www.ipracell.be/wp-content/uploads/2019/08/Material-Safety-Data-Sheet-HeLa-cytoplasmic-S100.pdf" class="wp-block-file__button" download>Download</a></div><p><strong>References</strong></p>
<ul><li><a href="https://mcb.asm.org/content/mcb/14/6/4160.full.pdf ">Plessel, G., Fischer, U. and Lührmann, R, (1994). m3G cap hypermethylation of U1 small nuclear ribonucleoprotein (SnRNP) in vitro: evidence that the U1 small nuclear RNA-(guanosine-N2)­methyltransferase is a non-SnRNP cytoplasmic protein that requires a binding site on the Sm core domain. Molecular and Cellular Biology 14, 4160-4172.</a></li></ul>]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
